Compound Detail
CHEMBL3809552
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL3809552 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | URGGLJWRKAXLOT-UHFFFAOYSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
354.4
MW (Da)
3.79
ALogP
6
HBA
4
HBD
111.1
PSA (Ų)
0.42
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 5.22
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 6000.0 | nM | 5.22 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability a... | 26841168 |
| MCF7 | IC50 | = | 7000.0 | nM | 5.16 | Cytotoxicity against human MCF7 cells assessed as reduction in cell viability af... | 26841168 |
| SW480 | IC50 | = | 12000.0 | nM | 4.92 | Cytotoxicity against human SW480 cells assessed as reduction in cell viability a... | 26841168 |
| A549 | IC50 | = | 20300.0 | nM | 4.69 | Cytotoxicity against human A549 cells assessed as reduction in cell viability af... | 26841168 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 26841168 | 10.1021/acs.jnatprod.5b00877 | HepG2 | 1 |
| 26841168 | 10.1021/acs.jnatprod.5b00877 | SW480 | 1 |
| 26841168 | 10.1021/acs.jnatprod.5b00877 | A549 | 1 |
| 26841168 | 10.1021/acs.jnatprod.5b00877 | MCF7 | 1 |
Data from ChEMBL 36 via Core Engine